Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl versus dexmedetomidine as adjuvant to intrathecal bupivacaine
PACTR202503471801855Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fentanyl, dexmedetomidine and bupivacaine in perioperative pain (3 arms), sponsored by Al-Azhar University. Started Aug 2024; status: recruiting.
02
Drugs
fentanyldexmedetomidinebupivacaine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on PACTR202503471801855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503471801855.